📣 VC round data is live. Check it out!
- Public Comps
- Teleflex
Teleflex Valuation Multiples
Discover Teleflex's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Sysmex, Ypsomed, Getinge, Andon Health and more.
Teleflex Overview
About Teleflex
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
Founded
1943
HQ

Employees
14.1K
Website
Financials (LTM)
EV
$8B
Valuation Multiples
Start free trialTeleflex Financials
Teleflex reported last 12-month revenue of $2B and EBITDA of $606M.
In the same LTM period, Teleflex generated $1B in gross profit, $606M in EBITDA, and $305M in net income.
Revenue (LTM)
Teleflex P&L
In the most recent fiscal year, Teleflex reported revenue of $2B and EBITDA of $609M.
Teleflex is profitable as of last fiscal year, with gross margin of 56%, EBITDA margin of 31%, and net margin of 16%.
Financial data powered by Morningstar, Inc.
Teleflex Stock Performance
Teleflex has current market cap of $6B, and enterprise value of $8B.
Market Cap Evolution
Teleflex's stock price is $125.24.
Teleflex share price decreased by 2.6% in the last 30 days, and increased by 5.8% in the last year.
Teleflex has an EPS (earnings per share) of $7.05.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8B | $6B | -1.8% | -2.6% | 4.7% | 5.8% | $7.05 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialTeleflex Valuation Multiples
Teleflex trades at 3.7x EV/Revenue multiple, and 13.1x EV/EBITDA.
EV / Revenue (LTM)
Teleflex Financial Valuation Multiples
As of June 3, 2026, Teleflex has market cap of $6B and EV of $8B.
Teleflex has a P/E ratio of 18.2x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Teleflex Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Teleflex Margins & Growth Rates
Teleflex grew revenue by 15% but EBITDA decreased by 1% in the last fiscal year.
In the most recent fiscal year, Teleflex reported gross margin of 56%, EBITDA margin of 31%, and net margin of 16%.
Teleflex Margins
Teleflex Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Teleflex Operational KPIs
Teleflex's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Teleflex's Rule of 40 is 41% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Teleflex's Rule of X is 63% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Teleflex Competitors
Teleflex competitors include Sysmex, Ypsomed, Getinge, Andon Health, Bausch + Lomb, Snibe, Abbott India, Renishaw, Sectra and Convatec Group.
Most Teleflex public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.7x | 1.7x | 7.2x | 8.6x | |||
| 6.4x | 6.4x | 14.3x | 14.6x | |||
| 1.6x | 1.6x | 8.6x | 8.6x | |||
| 25.2x | - | 12.7x | - | |||
| 2.0x | 1.9x | 11.4x | 10.7x | |||
| 7.2x | 6.9x | 16.1x | 15.7x | |||
| 7.7x | 7.6x | 24.6x | 27.7x | |||
| 5.1x | 4.7x | 22.8x | 20.8x | |||
This data is available for Pro users. Sign up to see all Teleflex competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Teleflex
Teleflex has acquired 9 companies to date.
Last acquisition by Teleflex was on February 27th 2025. Teleflex acquired BIoTronik (vascular intervention unit) for $821M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Teleflex
| Description | - | Palette Life Sciences is a Santa Clarita-headquartered life sciences company developing injectables for urology, urogynecology, colorectal, and oncology applications. Its portfolio includes Deflux for vesicoureteral reflux treatment, Barrigel for prostate radiotherapy spacing, Solesta for fecal incontinence, and Lidbree for pain management. Acquired by Boston Scientific in 2021 and spun out, Palette operates in the U.S. and Europe with FDA approvals since 2000. | Standard Bariatrics is a Cincinnati-based developer of laparoscopic instruments for bariatric surgery. Its flagship Standard Clamp standardizes sleeve gastrectomy procedures by applying consistent pressure and reducing tissue trauma during stomach resection. The device received FDA 510(k) clearance in 2016 and features ergonomic handles for improved surgeon control. Standard Bariatrics supplies hospitals and surgical centers in the United States and Europe, with clinical studies showing reduced operative times by 20 percent compared to traditional staplers. | Z-Medica is a U.S.-based medical device manufacturer specializing in hemostatic agents for external bleeding control. Its QuikClot products, used by military and first responders, feature zeolite-based gauze that accelerates clotting in trauma scenarios. Acquired by Teleflex in 2017, the company supplies dressings to hospitals and emergency services worldwide. | |
| HQ Country | |||||
| HQ City | - | Santa Barbara, CA | Cincinnati, OH | - | |
| Deal Date | 27 Feb 2025 | 26 Jul 2023 | 22 Aug 2022 | 28 Oct 2020 | |
| Valuation | $821M | $600M | $170M | $500M | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Teleflex acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Teleflex
| When was Teleflex founded? | Teleflex was founded in 1943. |
| Where is Teleflex headquartered? | Teleflex is headquartered in United States. |
| How many employees does Teleflex have? | As of today, Teleflex has over 14K employees. |
| Is Teleflex publicly listed? | Yes, Teleflex is a public company listed on NYSE. |
| What is the stock symbol of Teleflex? | Teleflex trades under TFX ticker. |
| When did Teleflex go public? | Teleflex went public in 1972. |
| Who are competitors of Teleflex? | Teleflex main competitors include Sysmex, Ypsomed, Getinge, Andon Health, Bausch + Lomb, Snibe, Abbott India, Renishaw, Sectra, Convatec Group. |
| What is the current market cap of Teleflex? | Teleflex's current market cap is $6B. |
| What is the current revenue of Teleflex? | Teleflex's last 12 months revenue is $2B. |
| What is the current revenue growth of Teleflex? | Teleflex revenue growth (NTM/LTM) is 10%. |
| What is the current EV/Revenue multiple of Teleflex? | Current revenue multiple of Teleflex is 3.7x. |
| What is the current EBITDA of Teleflex? | Teleflex's last 12 months EBITDA is $606M. |
| What is Teleflex's EBITDA margin? | Teleflex's last 12 months EBITDA margin is 29%. |
| What is the current EV/EBITDA multiple of Teleflex? | Current EBITDA multiple of Teleflex is 13.1x. |
| What is the current FCF of Teleflex? | Teleflex's last 12 months FCF is $318M. |
| What is Teleflex's FCF margin? | Teleflex's last 12 months FCF margin is 15%. |
| What is the current EV/FCF multiple of Teleflex? | Current FCF multiple of Teleflex is 24.9x. |
| How many companies Teleflex has acquired to date? | As of June 2026, Teleflex has acquired 9 companies. |
| What was the largest acquisition by Teleflex? | $1B acquisition of Neotract on 5th September 2017 was the largest M&A Teleflex has done to date. |
| In how many companies Teleflex has invested to date? | Teleflex hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Teleflex
Lists including Teleflex
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

